Welcome to LookChem.com Sign In|Join Free
  • or
3-Isoxazolecarboxylic acid, 5-[[(3-methoxyphenyl)thio]methyl]-, ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

823219-88-1

Post Buying Request

823219-88-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

823219-88-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 823219-88-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,3,2,1 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 823219-88:
(8*8)+(7*2)+(6*3)+(5*2)+(4*1)+(3*9)+(2*8)+(1*8)=161
161 % 10 = 1
So 823219-88-1 is a valid CAS Registry Number.

823219-88-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(3-Methoxy-phenylsulfanylmethyl)-isoxazole-3-carboxylic acid ethyl ester

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:823219-88-1 SDS

823219-88-1Relevant academic research and scientific papers

ISOXAZOLES AS PEPTIDE DEFORMYLASE INHIBITORS

-

Page/Page column 24; 32, (2010/02/11)

Isoxazole compounds of formula (I) and pharmaceutically acceptable salts or esters thereof are peptide deformylase inhibitors useful in the treatment or prevention of infections and other disease in which peptide deformylases are involved, especially in t

Sequential ring-closing metathesis/Pd-catalyzed, Si-assisted cross-coupling reactions: General synthesis of highly substituted unsaturated alcohols and medium-sized rings containing a 1,3-cis-cis diene unit

Denmark, Scott E.,Yang, Shyh-Ming

, p. 9695 - 9708 (2007/10/03)

A sequential ring-closing metathesis/silicon-assisted cross-coupling protocol has been developed. Alkenyldimethylsilyl ethers of allylic, homoallylic and bis(homoallylic) alcohols undergo facile ring closure with Schrock's catalyst to afford 5-, 6-, and 7-membered cycloalkenylsiloxanes, respectively, in some cases with substituents on both alkenyl carbons. These siloxanes are highly effective coupling partners that afford styrenes and dienes (with various aryl and alkenyl halides) in high yield and specificity as well as good functional group compatibility. The siloxanes bearing a Z-iodoalkenyl tether undergo an intramolecular coupling process in the presence of [allylPdCl] 2 which constitutes a powerful method for the construction of medium-sized rings with an internal 1,3-cis-cis diene unit. The formation of 9-, 10-, 11-, and 12-membered carbocyclic dienes is achieved in good yield. Extension to the synthesis of 9-membered ring unsaturated ethers has also been accomplished. Noteworthy features of this process include: (1) highly stereospecific intramolecular coupling, (2) flexible positioning of the revealed hydroxy group, and (3) potential extension to other medium-sized carbocycles and heterocycles. Graphical Abstract.

Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents

Calí, Patrizia,N?rum, Lars,Mukhija, Seema,Hjelmencrantz, Anders

, p. 5997 - 6000 (2007/10/03)

The synthesis and initial in vitro evaluation of isoxazole-3-hydroxamic acid derivatives as a new class of PDF inhibitors are reported. A series of isoxazole-3-hydroxamic acid derivatives has been identified as a new class of small, nonpeptidic inhibitors of peptide deformylase (PDF). The synthesis, enzyme inhibition and preliminary investigation of the binding mode of this potential antibacterial compounds are reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 823219-88-1